scispace - formally typeset
W

William E. Kraus

Researcher at Duke University

Publications -  625
Citations -  40583

William E. Kraus is an academic researcher from Duke University. The author has contributed to research in topics: Heart failure & Medicine. The author has an hindex of 93, co-authored 565 publications receiving 33692 citations. Previous affiliations of William E. Kraus include University of Texas Southwestern Medical Center & University of North Carolina at Chapel Hill.

Papers
More filters
Journal ArticleDOI

Epigenome-wide Association Study Analysis of Calorie Restriction in Humans, CALERIETM Trial Analysis

TL;DR: Although individual CpG site DNAm changes in response to CR were not identified, analyses of sets CpGs identified in prior EWAS revealed CR-induced changes to blood DNAm.
Journal ArticleDOI

Glyca, a novel biomarker of systemic inflammation, improves cardiovascular risk prediction in a high-risk coronary catheterization cohort

TL;DR: GlycA is a serum measurement of enzymatically glycosylated acute phase proteins that correlates with existing inflammatory biomarkers such as C-reactive protein and interleukin-6 and appears to characterize residual cardiovascular risk on top of traditional risk factors.
Journal ArticleDOI

A New Era in Cardiac Rehabilitation Delivery: Research Gaps, Questions, Strategies, and Priorities

TL;DR: In this paper , the authors describe important gaps in evidence, identify relevant research questions, and propose strategies for addressing them, and highlight four research priorities: (1) including diverse populations in all CR research; (2) leveraging implementation methodologies to enhance equitable delivery of CR; (3) clarifying which populations are most likely to benefit from virtual and remote CR; and (4) comparing traditional in-person CR with virtual or remote CR in diverse populations using multicenter studies of important clinical, psychosocial, and cost-effectiveness outcomes that are relevant to patients, caregivers, providers, health systems, and payors.
Journal ArticleDOI

Lifestyle modification and cognitive function among individuals with resistant hypertension: cognitive outcomes from the TRIUMPH trial

TL;DR: Cognitive performance improved across the entire cohort during the TRIUMPH trial and increased executive function/learning was associated with reduced ambulatory SBP levels secondary to weight loss, which appeared to be associated with reducing ambulatorySBP changes through weight loss.